Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q13315: Variant p.Ile2702Arg

Serine-protein kinase ATM
Gene: ATM
Feedback?
Variant information Variant position: help 2702 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Isoleucine (I) to Arginine (R) at position 2702 (I2702R, p.Ile2702Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (I) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AT. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 2702 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 3056 The length of the canonical sequence.
Location on the sequence: help TIQSFKAEFRLAGGVNLPKI I DCVGSDGKERRQLVKGRDDL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         TIQSFKAEFRLAGGVNLPKIIDCVGSDGKERRQLVKG-RDDL

Mouse                         TIKSFKTEFRLAGGLNLPKIIDCVGSDGKERRQLVKG-RDD

Pig                           TIQSFKPEFRLAGGLNLPKIIDCVGSDGKERRQLVKG-RDD

Caenorhabditis elegans        TWKRWKDVFTIADGISTPKIWEIEGSDGKWYKTVWK--KDD

Drosophila                    SVVKWTNETTQCGGLNAPVKIMCVCSDGKIRAQLVKG-KDD

Baker's yeast                 IVSVNETVGITTTGLSLPKIVTFNISDGTTQKALMKGSNDD

Fission yeast                 TVSSFDDTIHFASGINAPKVITCLGSNGHTYKQLVKGGNDD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 3056 Serine-protein kinase ATM
Domain 2686 – 2998 PI3K/PI4K catalytic
Mutagenesis 2685 – 2685 S -> T. No effect on phosphorylation of target proteins.
Mutagenesis 2699 – 2699 P -> L. Loss of phosphorylation of target proteins.
Mutagenesis 2708 – 2708 D -> N. Decreased phosphorylation of target proteins.
Beta strand 2700 – 2706



Literature citations
Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity.
Becker-Catania S.G.; Chen G.; Hwang M.J.; Wang Z.; Sun X.; Sanal O.; Bernatowska-Matuszkiewicz E.; Chessa L.; Lee E.Y.-H.P.; Gatti R.A.;
Mol. Genet. Metab. 70:122-133(2000)
Cited for: VARIANTS AT 35-ARG--VAL-3056 DEL; LEU-292; 393-TRP--VAL-3056 DEL; ARG-950; LEU-1082; 1171-GLN--VAL-3056 DEL; 1839-GLN--VAL-3056 DEL; GLU-2063; CYS-2227; 2246-CYS--THR-2252 DELINS HIS; 2547-ARG--SER-2549 DEL; GLU-2625; PRO-2626 AND ARG-2702; VARIANT CYS-49;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.